Nafimidone hydrochloride

Nafenopin.

Nafoxidine, a nonsteroidal estrogen antagonist, is shown to possess antitumor activity against breast cancer.

Nafoxidine, a nonsteroidal estrogen antagonist, is shown to possess antitumor activity against breast cancer.

Naftopidil is a selective α1-adrenergic receptor antagonist or alpha blocker with a Ki of 58.3 nM.N α-1-Adrenergic receptor antagonist and an antihypertensive.

Naftopidil is a selective α1-adrenergic receptor antagonist or alpha blocker with a Ki of 58.3 nM.N α-1-Adrenergic receptor antagonist and an antihypertensive.

Naftopidil is a selective α1-adrenergic receptor antagonist or alpha blocker with a Ki of 58.3 nM.N α-1-Adrenergic receptor antagonist and an antihypertensive.

Naftopidil DiHCl is a selective 5-HT1A and α1-adrenergic receptor antagonist with IC50 of 0.1 μM and 0.2 μM, respectively.

Naftopidil DiHCl is a selective 5-HT1A and α1-adrenergic receptor antagonist with IC50 of 0.1 μM and 0.2 μM, respectively.

NALFANepsilon-Di-Fmoc-D-lysine 98% 250mg

To be used in conjunction with Cayman&rsquos NAPE-PLD polyclonal antibody (aa 159-172) (Catalog No. 10305) to block protein-antibody complex formation during analysis of NAPE-PLD &middot N-acylethanolamines (NAEs) are involved in diverse

To be used in conjunction with Cayman&rsquos NAPE-PLD polyclonal antibody (aa 6-20) (Item No. 10306) to block protein-antibody complex formation during analysis of NAPE-PLD &middot N-acylethanolamines (NAEs) are involved in diverse biological

Nardosinone has inhibitory effect on Ang II-induced hypertrophy in H9c2 cells, might be mediated by targeting PI3K/Akt and MEK/ERK signaling pathways. Nardosinone could protect against the neuronal injury exposed to OGD, which may be relevant to